Verial
insightssandboxesdemoshealthcare-ai

Why Healthcare AI Companies Need a Sandbox, Not Just a Demo

A demo shows your agent works once. A sandbox proves it works across hundreds of scenarios, edge cases, and failure modes.

S
Stan Liu · Co-founder, Verial
·10 min read
Share

TL;DR

  • A demo proves your agent works once. A sandbox proves it works across hundreds of scenarios, edge cases, and failure modes. Health systems buy the second, not the first.
  • 80% of healthcare AI projects fail to scale past the pilot phase (Health Tech Digital, 2024). Most fail on integration, not model quality.
  • 77% of health systems cite lack of AI tool maturity as the top barrier to adoption (Scottsdale Institute survey, 2024).
  • Over 90% of US hospitals run FHIR-capable EHRs (ONC). The variability in how they expose data is where demos look great and pilots fall apart.

The demo trap

Every healthcare AI startup has a demo. The demo works. The agent pulls up the right patient, reads the chart correctly, submits the prior auth, gets the approval. The health system's CMIO nods approvingly. The sales team celebrates.

Then the pilot starts. The agent encounters a patient with three active insurance plans. It finds a Condition resource with no diagnosis code, just free text. The payer portal changed its login flow last Tuesday. The IVR system puts the agent on hold for 12 minutes. The agent that worked flawlessly in the demo fails on 15% of real cases in the first week.

This is the demo trap. A demo proves your agent can handle one scenario. A sandbox proves it can handle the scenarios that actually occur in production. The difference between the two is the difference between a signed LOI and a canceled pilot.

"We have to get this right. We have to solve digital health."

Grahame Grieve, FHIR Product Director, HL7

What health system buyers actually evaluate

If you have sold into health systems, you know that the clinical champion who saw your demo is not the only decision-maker. The procurement process involves IT security, compliance, clinical informatics, and often a formal evaluation committee. Each group asks different questions, and none of them are satisfied by a demo.

IT and integration teams

They want to know: "What happens when our EHR returns data your agent has never seen?" They are not asking hypothetically. They have been burned by vendors whose integrations broke after EHR upgrades, configuration changes, or data migrations. They want evidence that your agent handles the full range of data shapes their system produces, not just the five patients you showed in the demo.

A sandbox gives you this evidence. You can test against hundreds of synthetic patients with varying data completeness, different coding systems, and edge-case demographics. You can document exactly which data patterns your agent handles and which ones it escalates to a human. IT teams respect this level of rigor because it matches how they evaluate any integration.

Compliance and risk

They want to know: "What are the failure modes and how does the agent handle them?" In healthcare, a silent failure is worse than a loud one. An agent that quietly processes incorrect data creates liability. An agent that detects an issue and escalates to a human is safe.

Compliance teams want documentation of failure mode testing. What happens when the FHIR server is down? When the payer portal returns an unexpected error? When the patient's insurance information conflicts between systems? A demo cannot answer these questions. A sandbox with systematic failure injection can.

Clinical informatics

They want to know: "Does this work across our patient population, not just cherry-picked cases?" A health system serving a large Medicaid population has different data patterns than one serving primarily commercially insured patients. Pediatric facilities have different workflows than oncology centers. Rural health systems have different payer mixes than urban academic medical centers.

Clinical informaticists think in terms of population coverage. They want to see your agent tested against patient cohorts that resemble their population: demographics, insurance mix, condition prevalence, data completeness patterns. A demo with 5 well-curated patients does not answer this. A sandbox with 500 configurable patients does.

The sandbox advantage

A sandbox is not just a better demo. It is a fundamentally different tool. It provides three capabilities that demos cannot.

Deterministic testing

A sandbox produces the same results every time you run the same scenario. If your agent fails on a specific patient configuration, you can reproduce the failure reliably, fix it, and verify the fix. This is basic engineering practice for every other type of software, but healthcare AI teams often skip it because building realistic test environments is hard.

Determinism also enables regression testing. Every time you update your agent, you run it against the full scenario suite. If a code change breaks a previously passing scenario, you catch it before deployment. Without deterministic testing, regressions ship to production and surface as patient-impacting incidents.

Repeatability at scale

A demo takes a human 20 minutes to set up and run. A sandbox test suite runs in minutes, unattended. This means you can test hundreds of scenarios on every code change, not just the handful you can manually walk through before a deadline.

Scale changes what you can test. With 5 manual test cases, you test the happy path and maybe one error case. With 500 automated scenarios, you test every payer, every procedure type, every insurance configuration, every data shape, and every failure mode. The math is simple: more scenarios tested means fewer production surprises.

Parallelizable evaluation

When your team is preparing for a new health system deployment, you need to validate your agent against that system's specific configuration: their EHR vendor, their payer mix, their clinical workflows. With a sandbox, you can spin up a new environment configured to match the target system and run your full test suite against it. Multiple team members can test different aspects simultaneously.

This is impossible with demos. You cannot run 10 demos in parallel. You cannot have 5 engineers independently verifying different integration aspects against a live demo environment without stepping on each other's data.

Building governance-ready evidence

Health systems increasingly require formal evidence packages before approving AI deployments. The specifics vary, but most evaluation frameworks ask for some version of the following.

Test coverage documentation

What scenarios has the agent been tested against? What percentage of common workflows are covered? What edge cases have been explicitly tested? This is not a marketing document. It is a technical report with specific numbers.

A sandbox generates this documentation automatically. Each test run produces a record of the scenario, the agent's actions, and the outcome. Aggregate these records and you have a test coverage report that shows exactly what has been validated.

Failure mode catalog

What can go wrong and how does the agent handle it? Health systems want to see a catalog of known failure modes with the agent's response to each one: retry, escalate, alert, or degrade gracefully.

Building this catalog requires systematically injecting failures and recording the agent's behavior. A sandbox with configurable failure injection makes this straightforward. Run each failure scenario, record the outcome, document the agent's behavior. The result is a failure mode catalog that compliance teams can review and approve.

Performance benchmarks

How fast does the agent process a prior auth? What is the accuracy rate across different payers? How does performance vary with data completeness? These questions require statistical answers, not anecdotes.

Running your agent against hundreds of sandbox scenarios produces the data for these benchmarks. You can report: "Across 200 prior auth scenarios spanning 12 payers, the agent achieved 94% end-to-end completion with a median processing time of 4.2 minutes. The 6% failure rate was composed of 3% graceful escalations and 3% errors, which have been documented and addressed in version 2.1."

That sentence lands very differently than "the demo worked every time we showed it."

The path from sandbox to production

A sandbox is not a replacement for production validation. It is the step that makes production validation efficient and low-risk.

Phase 1: Full sandbox testing

Before any production deployment, run your agent against a sandbox configured to match the target health system. Test every workflow, every payer, every failure mode. Fix issues. Run again. Build the evidence package.

This phase is entirely risk-free. No real patients, no real data, no real payer interactions. Your team can iterate as many times as needed without burning goodwill with the health system.

Phase 2: Limited production pilot

With sandbox testing complete, move to a limited production pilot with a small patient cohort. The sandbox testing has already caught the obvious failures, so the pilot focuses on validating assumptions about real-world data patterns that the sandbox may not perfectly replicate.

The pilot goes better because the agent has already been tested against hundreds of scenarios. The failure rate is lower. The IT team sees fewer tickets. The clinical team gains confidence faster.

Phase 3: Monitored expansion

Expand the pilot to more patients, more payers, more workflows. Continue running sandbox tests in parallel to catch regressions. When production surfaces a new edge case, add it to the sandbox suite so it is tested automatically going forward.

This feedback loop between production and sandbox is what separates teams that scale smoothly from teams that fight fires at each new deployment. The sandbox grows with your production experience, becoming an increasingly accurate model of the real world.

The real cost of skipping the sandbox

Teams that go straight from demo to production pilot consistently experience the same pattern: the first two weeks go well because the agent handles common cases. Then the edge cases start appearing. The team scrambles to fix issues while the health system's confidence erodes. The pilot gets extended, then put on hold, then quietly shelved.

The investment in a sandbox is not optional for healthcare AI companies that want to deploy at scale. It is the engineering infrastructure that makes deployment possible. A demo gets you the meeting. A sandbox gets you the contract.

Key Takeaways

  • Demos close meetings. Sandboxes close contracts. Health system buyers evaluate evidence, not theater.
  • IT, compliance, and clinical informatics each ask questions a demo cannot answer. Sandboxes produce the evidence each team needs.
  • Deterministic, parallelizable testing is table stakes for every other kind of software. Healthcare AI should not get a pass.
  • Running 500 scenarios on every code change catches regressions before they become patient-impacting incidents.
  • The path from sandbox to production is faster, not slower. Integration bugs are caught in a safe environment.
  • Skipping sandbox testing produces a predictable failure pattern: demo success, pilot stall, shelved deal.

FAQ

What should a sandbox include beyond FHIR?

Production agents span multiple interfaces. A useful sandbox covers FHIR, payer portals, IVR or voice systems, HL7v2 feeds, and fax where relevant. Testing only FHIR leaves most failure modes uncovered.

How many scenarios should I run before a health system deployment?

At minimum, cover each workflow the agent performs, each payer or EHR vendor in scope, and each documented failure mode. For a prior auth agent deployment, that typically means 200 or more scenarios across the target payer mix.

What evidence do governance committees actually review?

Test coverage documentation, failure mode catalogs, and performance benchmarks. Committees want statistical answers: end-to-end completion rate, median processing time, escalation rate. Sandbox runs produce these automatically.

Can I skip the sandbox if I have a strong pilot?

Not without risk. Pilots surface common-case failures, not edge cases. A sandbox with 500 scenarios covers payer variations, data quality gaps, and failure modes a pilot will not see until production scale exposes them.

For a practical framework on how to structure that sandbox testing, see how to test healthcare AI agents.

S
Stan Liu · Co-founder, Verial
·10 min read
Share